Products for Research Use Only

MDA 19 (Standard)

CAT: 0804-HY-15451R-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-15451R-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
MDA 19 (Standard) is the analytical standard of MDA 19. This product is intended for research and analytical applications. MDA 19 is a potent and selective agonist of human cannabinoid receptor 2 (CB2), with a Ki of 43.3 nM. MDA 19 has antiallodynic effects in a rat model of neuropathic pain and does not affect rat locomotor activity[1][2].
CAS Number
1048973-47-2
Product Name Alternative
BZO-HEXOXIZID (Standard)
UNSPSC
12352005
Target
Cannabinoid Receptor; Reference Standards
Type
Reference Standards
Related Pathways
GPCR/G Protein; Neuronal Signaling; Others
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/mda-19-standard.html
Smiles
O=C(C1=CC=CC=C1)N/N=C2C(N(C3=C\2C=CC=C3)CCCCCC)=O
Molecular Formula
C21H23N3O2
Molecular Weight
349.43
References & Citations
[1]Diaz, Philippe; Xu, Jijun; Astruc-Diaz, Fanny et al. Design and Synthesis of a Novel Series of N-Alkyl Isatin Acylhydrazone Derivatives that Act as Selective Cannabinoid Receptor 2 Agonists for the Treatment of Neuropathic Pain. Journal of Medicinal Chemistry (2008), 51 (16), 4932-4947.|[2]Xu JJ, Diaz P, Astruc-Diaz F et al. Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain. Anesth Analg. 2010 Jul;111 (1) :99-109.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Clinical Information
No Development Reported